阿科力(603722.SH)擬出資1000萬元參與設立無錫劦律投資管理合夥企業
格隆匯10月21日丨阿科力(603722.SH)公佈,公司擬出資人民幣1000萬元參與投資設立無錫劦律投資管理合夥企業(有限合夥)(以下簡稱“合夥企業”)。
合夥企業經營範圍包括股權投資、創業投資、對非上市公司的股權等非公開交易的股權進行投資以及相關服務。
本次投資有利於在保障公司主營業務正常開展的前提下,合理配置資金,把握資本市場項目的投資機會,拓寬公司投資領域,獲得資本增值收益,提高公司盈利水平和市場競爭力。本次投資與公司主營業務不存在衝突,此項合作投資事項不會導致同業競爭。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.